Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

Flotte TR et al. Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector Proc Natl Acad Sci USA 1993 90: 10613–10617

Kessler PD et al. Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein Proc Natl Acad Sci USA 1996 93: 14082–14087

Xiao X, Li J, Samulski RJ . Efficient long-term gene transfer into muscle tissue of immunocompetent mice by adeno-associated virus vector J Virol 1996 70: 8098–8108

Clark KR, Sferra TJ, Johnson PR . Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle Hum Gene Ther 1997 8: 659–669

Fisher KJ et al. Recombinant adeno-associated virus for muscle directed gene therapy Nature Med 1997 3: 306–312

Klein RL et al. Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors Exp Neurol 1998 150: 183–194

Peel AL et al. Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters Gene Therapy 1997 4: 16–24

Flannery JG et al. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus Proc Natl Acad Sci USA 1997 94: 6916–6921

Lewin AS et al. Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosa Nature Med 1998 4: 967–971

Snyder RO et al. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors Nat Genet 1997 16: 270–276

Hermonat PL et al. Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants J Virol 1984 51: 329–339

McLaughlin SK et al. Adeno-associated virus general transduction vectors: analysis of proviral structures J Virol 1988 62: 1963–1973

Jooss K et al. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers J Virol 1998 72: 4212–4223

Flotte T et al. A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease Hum Gene Ther 1996 7: 1145–1159

Wagner JA et al. Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus Lancet 1998 351: 1702–1703

Hermonat PL, Muzyczka N . Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells Proc Natl Acad Sci USA 1984 81: 6466–6470

Li J, Samulski RJ, Xiao X . Role for highly regulated rep gene expression in adeno-associated virus vector production J Virol 1997 71: 5236–5243

Grimm D, Kern A, Rittner K, Kleinschmidt J . Novel tools for production and purification of recombinant AAV vectors Hum Gene Ther 1998 9: 2745–2760

Xiao X, Li J, Samulski RJ . Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus J Virol 1998 72: 2224–2232

Salvetti A et al. Factors influencing recombinant adeno-associated virus production Hum Gene Ther 1998 9: 695–706

Chiorini JA et al. High-efficiency transfer of the T cell co-stimulatory molecule B7–2 to lymphoid cells using high-titer recombinant adeno-associated virus vectors Hum Gene Ther 1995 6: 1531–1541

Conway JE et al. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap J Virol 1997 71: 8780–8789

Inoue N, Russell DW . Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors J Virol 1998 72: 7024–7031

Clark KR et al. Cell lines for the production of recombinant adeno-associated virus Hum Gene Ther 1995 6: 1329–1341

Summerford C, Samulski RJ . Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions J Virol 1998 72: 1438–1445

Zolotukhin S et al. A ‘humanized’ green fluorescent protein cDNA adapted for high-level expression in mammalian cells J Virol 1996 70: 4646–4654

Tamayose K, Hirai Y, Shimada T . A new strategy for large-scale preparation of high-titer recombinant adeno-associated virus vectors by using packaging cell lines and sulfonated cellulose column chromatography Hum Gene Ther 1996 7: 507–513

Neyts J et al. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate Virology 1992 189: 48–58

Nadcarni VD, Pervin A, Linahrdt RJ . Directional immobilization of heparin to beaded supports Anal Biochem 1994 222: 59–67

Herold BC et al. Identification of structural features of heparin required for inhibition of herpes simplex type I binding Virology 1995 206: 1108–1116

Ferrari FK et al. Second-strand synthesis is a rate-limiting step for efficient transduction by recombinant adeno-associated virus vectors J Virol 1996 70: 3227–3234

Samulski RJ, Chang LS, Shenk T . Helper-free stocks of recombinant adeno-associated viruses: normal integration does not require viral gene expression J Virol 1989 63: 3822–3828

Russell DW, Miller AD, Alexander IE . Adeno-associated virus vectors preferentially transduce cells in S phase Proc Natl Acad Sci USA 1994 91: 8915–8919

Alexander IE, Russell DW, Miller AD . Transfer of contaminants in adeno-associated virus vector stocks can mimic transduction and lead to artifactual results Hum Gene Ther 1997 8: 1911–1920

Fisher KJ et al. Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis J Virol 1996 70: 520–532

Hardy S et al. Construction of adenovirus vectors through Cre-lox recombination J Virol 1997 71: 1842–1849

Heim R, Tsien R . Engineering green fluorescent protein for improved brightness, longer wavelength and fluorescence resonance energy transfer J Virol 1996 70: 4646–4654

Snyder RO, Xiao X, Samulski RJ . Production of recombinant adeno-associated viral vectors. In: Dracopoli N (ed) . Current Protocols in Human Genetics John Wiley: New York 1996 12.1.1–12.1.20